U.S. market Open. Closes in 2 hours 58 minutes

GOSS | Gossamer Bio, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for GOSS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak.

Valuation (14%)

Company Industry
P/E Ratio (TTM) -2.70 -20.30
PEG Ratio (TTM) -0.15 -5.71
P/S Ratio (TTM) 1.73 50.88
P/B Ratio (TTM) 3.57 29.28
P/FCF Ratio (TTM) -1.64 -8.95
Price to 5YR AVG Earnings Ratio -0.30 -6.52
Price to 5YR AVG FCF Ratio -1.09 -14.78

Profitability (25%)

Company Industry
ROA (TTM) -20.42% -18.85%
ROE (TTM) -127.28% 25.35%
Net Profit Margin (TTM) -63.91% -827.80%
ROIC 5YR AVG 37.16% -26.10%

Growth (30%)

4QTR AVG 3YR AVG 5YR AVG
EPS 15.42% -12.58% 7.08%
Revenue -47.53% N/A N/A
Net Income 11.86% -20.39% -6.49%
Cash Flow 35.39% -70.87% -39.35%

Health (33%)

Company Industry
Current Ratio (TTM) 6.74 6.09
Quick Ratio (TTM) 6.74 5.87
D/E Ratio (TTM) 3.64 1.00
Interest Coverage (TTM) -5.23 -9.57
Piotroski F-Score 3 4
Altman Z-Score N/A 13.84
LTL to 5YR AVG FCF -1.11 0.07
Shares Outstanding Growth 5YR AVG 23.70% 44.11%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙